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General:  All glassware, stirrer bars, syringes, and needles were either oven- or 
flame-dried prior to use.  All reagents, unless otherwise indicated, were obtained 
from commercial sources.  Anhydrous CH2Cl2 and MeCN were distilled from CaH2 
under N2.  Reactions were conducted under N2 or Ar atmospheres.  Thin layer 
chromatography (TLC) was performed on Merck 0.25-mm silica gel (Merck Art. 
5715).  Column chromatography was performed over Kieselgel 60 (Merck, 70–230 
mesh).  Melting points are determined using a Fargo MP-2D melting point apparatus.  
Fluorescence spectra were recorded using a Varian Cary Eclipse spectrometer.  In 
NMR spectra, the deuterated solvent was used as the lock, while either the solvent’s 
residual protons or TMS was employed as the internal standard.  Chemical shifts are 
reported in parts per million (ppm).  Multiplicities are given as s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), and br (broad). 
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Scheme S1 
 
Amine S-1.  A mixture of aniline (0.90 g, 9.7 mmol), 4-tert-butylbenzyl bromide 
(4.84 g, 21.3 mmol), and Na2CO3 (5.36 g, 38.8 mmol) in CH3CN (80 mL) was heated 
under reflux for 3 h.  The solvent was then evaporated under reduced pressure and 
the residue partitioned between CH2Cl2 (100 mL) and H2O (100 mL).  The organic 
phase was dried (MgSO4), concentrated, and purified (SiO2; hexanes/CH2Cl2, 9:1) to 
afford the amine S-1 as a colorless oil (3.55 g, 95%).  1H NMR (400 MHz, CDCl3) δ 
1.33 (s, 18 H), 4.62 (s, 4 H), 6.67 (t, J = 8 Hz, 1 H), 6.74 (d, J = 8 Hz, 2 H), 7.13 (d, J 
= 8 Hz, 2 H), 7.15 (d, J = 8 Hz, 4 H), 7.32 (d, J = 8 Hz, 4 H); 13C NMR (100 MHz, 
CDCl3) δ 31.5, 34.5, 53.8, 112.2, 116.3, 125.4, 126.2, 129.0, 135.4, 149.1, 149.5; 
HRMS (ESI): m/z [M + H]+ C28H36N calcd. 386.2847, found 386.2878. 
 
Amine S-3.  A solution of the amine S-1 (3.0 g, 7.8 mmol) and 
3,4-dichlorocyclobutene-1,2-dione (S-2) (1.74 g, 11.5 mmol)[a] in toluene (50 mL) 
was heated under reflux for 48 h.  The solvent was evaporated under reduced 
pressure and the residue purified (SiO2; hexanes/CH2Cl2, 2:1) to afford the amine S-3 
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as a yellow solid (1.56 g, 40%).  M.p. 187 °C; 1H NMR (400 MHz, CDCl3) δ 1.31 (s, 
18 H), 4.73 (s, 4 H), 6.85 (d, J = 8 Hz, 2 H), 7.10 (d, J = 8 Hz, 4 H), 7.35 (d, J = 8 Hz, 
4 H), 8.08 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 31.4, 34.6, 53.8, 112.3, 
114.9, 125.8, 125.9, 131.5, 132.9, 150.4, 154.2, 172.1, 186.0, 189.8, 195.4; HRMS 
(ESI): m/z [M + Na]+ C32H34ClNO2Na calcd. 522.2176, found 522.2197. 
 
a) R. C. De Selms, C. J. Fox, R. C. Riordan, Tetrahedron Lett. 1970, 10, 781-782. 
 
Amine S-4.  TFA (3 mL) and 2 N HCl(aq) (3 mL) were added to a solution of the 
amine S-3 (1.0 g, 2.0 mmol) in CH2Cl2 (6 mL) and acetone (24 mL).  After heating 
under reflux for 48 h, the organic solvent was evaporated under reduced pressure.  
The residue was added to petroleum ether (30 mL) and the precipitate was filtered off 
to afford the amine S-4 as a yellow solid (0.87 g, 90%).  M.p. 225 °C; 1H NMR (400 
MHz, CD3SOCD3) δ 1.25 (s, 18 H), 4.72 (s, 4 H), 6.83 (d, J = 8 Hz, 2 H), 7.14 (d, J = 
8 Hz, 4 H), 7.33 (d, J = 8 Hz, 4 H), 7.74 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, 
CD3SOCD3) δ 31.2, 34.2, 53.3, 112.0, 116.5, 125.2, 126.1, 128.3, 134.5, 149.1, 150.8, 
172.7, 193.9, 194.8 (one signal is missing possibly because of signal overlapping); 
HRMS (ESI): m/z [M + Na]+ C32H35NNaO3 calcd. 504.2514, found 504.2562. 
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Scheme S2 
 
Bromide S-5.  A mixture of N-methylaniline (2.3 g, 21.5 mmol), 1,8-dibromooctane 
(7.9 g, 29 mmol), and Na2CO3 (3.1 g, 29.2 mmol) in CH3CN (100 mL) was heated 
under reflux for 48 h and then the organic solvent was evaporated under reduced 
pressure.  The residue was partitioned between CH2Cl2 (100 mL) and H2O (100 mL) 
and then the organic layer was dried (MgSO4), concentrated, and purified (SiO2; 
hexanes/CH2Cl2, 10:1) to afford the bromide S-5 as a yellow oil (3.27 g, 51%).  1H 
NMR (400 MHz, CDCl3) δ 1.24–1.36 (br, 6 H), 1.36–1.46 (br, 2 H), 1.53–1.61 (br, 2 
H), 1.84 (m, 2 H), 2.91 (s, 3 H), 3.28 (t, J = 8 Hz, 2 H), 3.40 (t, J = 8 Hz, 2 H), 
6.63–6.68 (m, 3 H), 7.20 (t, J = 8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 26.7, 27.1, 
28.2, 28.8, 29.4, 32.8, 34.1, 38.4, 52.8, 111.9, 115.7, 129.0, 149.1; HRMS (ESI): m/z 
[M + H]+ C15H25BrN calcd. 298.1170, found 298.1195. 
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Bromide 5-short.  A solution of the bromide S-5 (0.61 g, 2.05 mmol) and the amine 
S-4 (1.0 g, 2.05 mmol) in 1-butanol/triethyl orthoformate (5:1, 60 mL) was heated 
under reflux for 6 h.  The solvent was evaporated under reduced pressure and the 
residue purified (SiO2; hexane/EtOAc, 1:1) to afford the bromide 5-short as a green 
solid (0.94 g, 59%).  M.p. 190 °C; 1H NMR (400 MHz, CDCl3) δ 1.31 (s, 18 H), 
1.35 (br, 6 H), 1.40–1.48 (br, 2 H), 1.62–1.70 (br, 2 H), 1.85 (m, 2 H), 3.15 (s, 3 H), 
3.40 (t, J = 8 Hz, 2 H), 3.48 (t, J = 8 Hz, 2 H), 4.74 (s, 4 H), 6.73 (d, J = 9 Hz, 2 H), 
6.86 (d, J = 9 Hz, 2 H), 7.11 (d, J = 8 Hz, 4 H), 7.36 (d, J = 8 Hz, 4 H), 8.33 (d, J = 9 
Hz, 2 H), 8.37 (d, J = 9 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 27.2, 27.6, 28.4, 
29.0, 29.6, 31.7, 33.0, 34.3, 34.9, 39.3, 53.1, 54.0, 112.5, 113.1, 119.9, 120.8, 126.0, 
126.3, 133.2, 133.7, 150.7, 154.6, 154.7, 183.2, 187.9, 189.8 (one signal is missing 
possibly because of signal overlapping); HRMS (ESI): m/z [M + H]+ C47H58BrN2O2 
calcd. 783.3501, found 783.3553. 
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Bromide S-6.  A mixture of N-methylaniline (0.500 g, 4.67 mmol), 
1,16-dibromohexdecane (3.59 g, 9.35 mmol), and Na2CO3 (1.29 g, 9.34 mmol) in 
CH3CN (30 mL) was heated under reflux for 48 h.  After evaporating the solvent 
under reduced pressure, the residue was partitioned between CH2Cl2 (100 mL) and 
H2O (100 mL).  The organic layer was dried (MgSO4), concentrated, and purified 
(SiO2; hexanes/CH2Cl2, 10:1) to afford the bromide S-6 as a white solid (1.17 g, 61%).  
M.p. 38 °C ; 1H NMR (400 MHz, CDCl3) δ 1.20–1.36 (br, 22 H), 1.38–1.48 (br, 2 H), 
1.52–1.62 (br, 2 H), 1.84 (m, 2 H), 2.91 (s, 3 H), 3.28 (t, J = 8 Hz, 2 H), 3.40 (t, J = 8 
Hz, 2 H), 6.65–6.69 (m, 3 H), 7.20 (t, J = 8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
26.7, 27.3, 28.3, 28.9, 29.5, 29.65, 29.71, 29.74, 32.9, 34.1, 38.3, 52.9, 112.0, 115.6, 
129.0, 149.1 (five signals are missing, possibly because of signal overlapping); 
HRMS (ESI): m/z [M + H]+ C23H41BrN calcd. 410.2422, found 410.2411. 
 
Bromide 5-long.  A solution of the bromide S-6 (0.500 g, 1.22 mmol) and the amine 
S-4 (0.590 g, 1.23 mmol) in 1-butanol/triethyl orthoformate (5:1, 50 mL) was heated 
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under reflux for 6 h.  The solvent was then evaporated under reduced pressure and 
the residue purified (SiO2; hexane/EtOAc, 1:1) to afford the bromide 5-long as a 
green solid (0.65 g, 61%).  M.p. 194 °C; 1H NMR (400 MHz, CDCl3) δ 1.20–1.45 
(m, 42 H), 1.62–1.70 (m, 2 H), 1.84 (m, 2 H), 3.15 (s, 3 H), 3.39 (t, J = 8 Hz, 2 H), 
3.49 (t, J = 8 Hz, 2 H), 4.74 (s, 4 H), 6.72 (d, J = 9 Hz, 2 H), 6.85 (d, J = 9 Hz, 2 H), 
7.11 (d, J = 8 Hz, 4 H), 7.35 (d, J = 8 Hz, 4 H), 8.35 (d, J = 9 Hz, 2 H), 8.37 (d, J = 9 
Hz, 2 H) ; 13C NMR (100 MHz, CDCl3) δ 27.3, 27.7, 28.6, 29.2, 29.79, 29.84, 29.9, 
30.01, 30.03, 31.7, 31.7, 33.2, 34.5, 34.9, 39.4, 53.3, 54.1, 112.6, 113.2, 119.9, 120.8, 
126.1, 126.4, 133.1, 133.2, 133.7, 150.7, 154.7, 183.2, 187.8, 189.9 (four signals are 
missing, possibly because of signal overlapping); HRMS (ESI): m/z [M + H]+ 
C55H74BrN2O2 calcd. 873.4933, found 873.4911. 
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Scheme S4 
 
Bromide S-7.  A mixture of 1-bromo-3,5-bis(bromomethyl)benzene (5.00 g, 14.6 
mmol), 4-tert-butylphenol (4.82 g, 32.1 mmol), and K2CO3 (8.87 g, 64.2 mmol) in 
DMF (50 mL) was stirred at 50 °C for 6 h and then the solvent was evaporated under 
reduced pressure.  The residue was partitioned between CH2Cl2 (100 mL) and H2O 
(100 mL) and then the organic layer was dried (MgSO4) and concentrated.  The 
crude product was purified (SiO2; hexanes/CH2Cl2, 1:1) to afford the bromide S-7 as a 
colorless oil (5.62 g, 80%).  1H NMR (400 MHz, CDCl3) δ 1.30 (s, 18 H), 5.01 (s, 4 
H), 6.88 (d, J = 8 Hz, 4 H), 7.29 (d, J = 8 Hz, 4 H), 7.40 (s, 1 H), 7.53 (s, 2 H); 13C 
NMR (100 MHz, CDCl3) δ 31.6, 34.2, 69.0, 114.1, 122.7, 124.5, 126.2, 129.5, 139.7, 
143.8, 156.0; HRMS (ESI): m/z [M + Na]+ C28H33BrNaO2 calcd. 503.1561, found 
503.1531. 
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Pyridine 8.  Aqueous Na2CO3 (2 M, 24 mL) was added to a solution of the bromide 
S-7 (2.40 g, 5.00 mmol), tetrakis(triphenylphosphine)palladium(0) (0.58 g, 0.50 
mmol), and 4-pyridineboronic acid (0.92, 7.5 mmol) in degassed toluene (40 mL) and 
MeOH (24 mL) at room temperature and then the mixture was heated under reflux for 
16 h.  The organic solvent was evaporated under reduced pressure and the residue 
partitioned between CH2Cl2 (100 mL) and H2O (100 mL).  The organic layer was 
dried (MgSO4), concentrated, and purified (SiO2; hexane/EtOAc, 6:1) to afford the 
pyridine 8 as a pale-yellow oil (1.93 g, 81%).  1H NMR (400 MHz, CDCl3) δ 1.28 (s, 
18 H), 5.12 (s, 4 H), 6.92 (d, J = 8 Hz, 4 H), 7.31 (d, J = 8 Hz, 4 H), 7.54 (d, J = 8 Hz, 
2 H), 7.57 (s, 1 H), 7.65 (s, 2 H), 8.65 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) 
δ 31.6, 34.2, 69.6, 114.1, 121.7, 125.4, 126.2, 126.9, 138.60, 138.65, 143.7, 147.9, 
149.9, 156.1; HRMS (ESI): m/z [M + H]+ C33H38NO2 calcd. 480.2902, found 
480.2900. 
 
Aldehyde S-8.  Aqueous Na2CO3 (2 M, 29 mL) was added to a solution of the 
bromide S-7 (2.8 g, 5.8 mmol), tetrakis(triphenylphosphine)palladium(0) (0.67 g, 0.58 
mmol), and 4-formylphenylboronic acid (1.05, 6.98 mmol) in degassed toluene (48 
mL) and MeOH (29 mL) at room temperature and then the mixture was heated under 
reflux for 16 h.  The organic solvent was evaporated under reduced pressure and the 
residue partitioned between CH2Cl2 (100 mL) and H2O (100 mL).  The organic layer 
was dried (MgSO4), concentrated, and purified (hexane/CH2Cl2, 2:1) to afford the 
pyridine S-8 as a colorless oil (2.65 g, 90%).  1H NMR (400 MHz, CDCl3) δ 1.33 (s, 
18 H), 5.13 (s, 4 H), 6.95 (d, J = 8 Hz, 4 H), 7.32 (d, J = 8 Hz, 4 H), 7.56 (s, 1 H), 
7.66 (s, 2 H), 7.76 (d, J = 8 Hz, 2 H), 7.95 (d, J = 8 Hz, 2 H), 10.05 (s, 1 H); 13C NMR 
(100 MHz, CDCl3) δ 31.8, 34.4, 39.8, 114.0, 125.5, 125.9, 126.1, 127.4, 129.8, 134.9, 
138.1, 139.9, 143.3, 146.1, 155.8, 191.0; HRMS (ESI): m/z [M + Na]+ C35H38NaO3 
calcd. 529.2719, found 529.2770. 
 
Alcohol S-9.  NaBH4 (0.3 g, 7.9 mmol) was added to a solution of the aldehyde S-8 
(2.00 g, 3.95 mmol) in MeOH (25 mL) and CH2Cl2 (25 mL) at room temperature and 
then the mixture was stirred for 4 h.  The solvent was evaporated under reduced 
pressure and the residue partitioned between CH2Cl2 (50 mL) and H2O (50 mL).  
The organic layer was dried (MgSO4), concentrated, and purified (SiO2; 
hexane/EtOAc, 1:1) to afford the alcohol S-9 as a colorless oil (1.65 g, 82%).  1H 
NMR (400 MHz, CDCl3) δ 1.30 (s, 18 H), 4.74 (d, J = 6 Hz, 2 H), 5.10 (s, 4 H), 6.93 
(d, J = 8 Hz, 4 H), 7.30 (d, J = 8 Hz, 4 H), 7.43 (d, J = 8 Hz, 2 H), 7.48 (s, 1 H), 7.58 
(d, J = 8 Hz, 2 H), 7.59 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 31.6, 34.1, 65.0, 70.0, 
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114.2, 125.3, 125.6, 126.1, 127.2, 127.3, 138.0, 139.8, 140.0, 141.3, 143.5, 156.3; 
HRMS (ESI): m/z [M + Na]+ C35H40NaO3 calcd. 531.2875, found 531.2896. 
 
Bromide 7.  PBr3 (1.32 g, 4.86 mmol, 1.5 equiv) was added slowly to a solution of 
the alcohol S-9 (1.65 g, 3.25 mmol) in CH2Cl2 (60 mL) at 0 °C.  The mixture was 
then stirred at room temperature for 3 h before being partitioned between ice water 
(50 mL) and CH2Cl2 (50 mL).  The organic layer was dried (MgSO4), concentrated, 
and purified (SiO2; CH2Cl2/hexane, 4:1) to afford the bromide 7 as a white solid (0.93 
g, 50%).  M.p. 39 °C; 1H NMR (400 MHz, CDCl3) δ 1.33 (s, 18 H), 4.55 (s, 2 H), 
5.12 (s, 4 H), 6.95 (d, J = 8 Hz, 4 H), 7.33 (d, J = 8 Hz, 4 H), 7.47 (d, J = 8 Hz, 2 H), 
7.51 (s, 1 H), 7.57 (s, 2 H), 7.60 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
31.6, 33.3, 34.1, 69.7, 114.1, 125.48, 125.52, 126.1, 127.4, 129.3, 136.8, 138.1, 140.5, 
140.8, 143.5, 156.2; HRMS (ESI): m/z [M + Na]+ C35H39BrNaO2 calcd. 593.2030, 
found 593.2011. 
  
Rotaxane [9·Na2][3ClO4].  The pyridine 8 (0.19 g, 0.39 mmol) was added to a 
solution of the bromide 5-short (0.2 g, 0.26 mmol), the molecular cage 1 (0.23 g, 0.26 
mmol), and NaClO4 (0.08 g, 0.65 mmol) in CH3CN (4 mL) and then the mixture was 
stirred at 50 °C for 7 days.  Saturated aqueous NaClO4 (5 mL) was added to the 
solution and the organic solvent was evaporated under reduced pressure.  The 
residue was extracted by CH2Cl2 (10 mL × 2) and the organic layer was collected and 
evaporated under reduced pressure.  The residue was then purified (SiO2; 
CH2Cl2/CH3CN, 17:3) to afford rotaxane [9·Na2][3ClO4] as a deep-blue solid (0.11 g, 
18%).  M.p. > 155 °C (dec.); 1H NMR (400 MHz, CD3CN) δ 1.24–1.42 (m, 64 H), 
1.70–1.78 (m, 2 H), 1.98–2.06 (m, 2 H), 3.24 (s, 3 H), 3.55–4.25 (m, 34 H), 4.48 (t, J 
= 8 Hz, 2 H), 5.04 (s, 4 H), 5.17 (s, 4 H), 6.12 (s, 4 H), 6.23 (s, 4 H), 6.74 (d, J = 8 Hz, 
2 H), 6.78 (d, J = 8 Hz, 2 H), 6.92 (d, J = 8 Hz, 4 H), 7.29–7.34 (m, 8 H), 7.37 (d, J = 
8 Hz, 2 H), 7.47 (d, J = 8 Hz, 4 H), 7.74 (d, J = 8 Hz, 2 H), 7.79 (s, 1 H), 7.92 (s, 2 H), 
8.24 (d, J = 8 Hz, 2 H), 8.63 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, CD3CN) δ 18.0, 
18.2, 26.0, 26.8, 27.4, 29.1, 29.4, 31.1, 31.2, 34.1, 34.6, 35.8, 39.0, 40.9, 52.4, 60.0, 
61.4, 66.3, 66.6, 68.8, 69.1, 103.1, 112.3, 113.3, 114.5, 125.4, 125.9, 126.6, 126.7, 
126.8, 130.3, 132.1, 133.5, 134.4, 135.3, 138.3, 138.5, 140.0, 143.7, 143.9, 144.0, 
144.6, 150.4, 153.4, 155.2, 155.7, 156.3, 179.8, 183.3, 185.9 (seven signals are 
missing, possibly because of signal overlapping); HRMS (ESI): m/z [9·Na2]3+ 
C132H154N3Na2O16 calcd. 694.3708, found 694.3722. 
 
Pyridinium salt 6-short·Br.  A solution of bromide 5-short (0.50 g, 0.64 mmol) and 
4,4´-bipyridyl (2.06 g, 13.2 mmol) in CH3CN (80 mL) was heated under reflux for 2 
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days and then the solvent was evaporated under reduced pressure.  The residue was 
washed with toluene (200 mL) to remove excess bipyridyl and then it was dried under 
vacuum to afford the pyridinium salt 6-short·Br (460 mg, 79%), which was used 
directly in the next step without further purification. M.p. > 180 °C ; 1H NMR (400 
MHz, CD3CN) δ 1.28 (s, 18 H), 1.20–1.40 (m, 8 H), 1.50–1.60 (m, 2 H), 1.90–2.00(m, 
2H), 3.05 (s, 3 H), 3.43 (t, J = 7.6 Hz, 2 H), 4.50 (t, J = 7.6 Hz, 2 H), 4.74 (s, 4 H), 
6.76 (d, J = 8 Hz, 2 H), 6.78 (d, J = 8 Hz, 2 H), 7.11 (d, J = 8 Hz, 4 H), 7.34 (d, J = 8 
Hz, 4 H), 7.74 (d, J = 8 Hz, 2 H), 8.04 (d, J = 8 Hz, 2 H), 8.14 (d, J = 8 Hz, 2 H), 8.26 
(d, J = 8 Hz, 2 H), 8.72 (d, J = 8 Hz, 2 H), 8.78 (d, J = 8 Hz, 2 H) ; 13C NMR (100 
MHz, CD3CN) δ 26.9, 27.6, 28.3, 29.9, 30.1, 32.1, 32.2, 35.6, 39.9, 53.8, 55.5, 62.9, 
114.4, 114.6, 120.2, 121.2, 123.1, 127.0, 127.2, 127.6, 132.9, 134.0, 135.1, 142.5, 
146.0, 151.6, 152.2, 155.0, 155.1, 156.2, 183.6, 186.5, 189.6 ; HRMS (ESI): m/z 
[6-short]+ C57H65N4O2+ calcd. 837.5106, found 837.5131. 
 
Rotaxane [4-short·Na2][4ClO4].  The bromide 7 (0.45 g, 0.80 mmol) was added to 
a solution of 6-short·Br (0.48 g, 0.53 mmol), the molecular cage 1 (0.46 g, 0.53 
mmol), and NaClO4 (0.163 g, 1.33 mmol) in CH3CN (4 mL) and then the mixture was 
stirred at 50 °C for 7 days.  Saturated aqueous NaClO4 (6 mL) was added to the 
solution and the organic solvent was evaporated under reduced pressure.  The 
residue was extracted by CH2Cl2 (10 mL × 2) and the organic layer was collected and 
evaporated under reduced pressure.  The residue was then purified (SiO2; 
CH2Cl2/CH3CN, 3:1) to afford the rotaxane [4-short·Na2][4ClO4] as a deep-blue solid 
(0.33 g, 24%).  M.p. > 175 °C (dec.); 1H NMR (400 MHz, CD3CN) δ 1.26–1.47 (m, 
64 H), 1.68–1.78 (br, 2 H), 1.98–2.08 (br, 2 H), 3.25 (s, 3 H), 3.62–4.26 (m, 34 H), 
4.63 (t, J = 8 Hz, 2 H), 5.04 (s, 4 H), 5.14 (s, 4 H), 5.87 (s, 2 H), 6.12 (s, 4 H), 6.24 (s, 
4 H), 6.74 (d, J = 8 Hz, 2 H), 6.80 (d, J = 8 Hz, 2 H), 6.91 (d, J = 8 Hz, 4 H), 
7.29–7.33 (m, 8 H), 7.38 (d, J = 8 Hz, 2 H), 7.47 (d, J = 8 Hz, 4 H),7.55 (s, 1 H), 7.59 
(d, J = 8 Hz, 2 H), 7.67 (s, 2 H), 7.70–7.80 (m, 4 H), 8.39–8.42 (m, 4 H), 8.92 (d, J = 
8 Hz, 2 H), 9.00 (d, J = 8 Hz, 2 H); 13C NMR (100 MHz, CD3CN) δ 18.0, 18.2, 26.1, 
26.9, 27.4, 29.2, 29.4, 31.0, 31.1, 31.4, 34.1, 34.6, 35.7, 38.9, 40.9, 52.4, 55.9, 62.4, 
64.7, 66.3, 66.6, 68.6, 68.7, 69.6, 103.1, 112.3, 113.3, 114.5, 125.8, 125.9, 126.5, 
126.6, 126.8, 127.5, 127.7, 128.2, 130.2, 132.1, 132.2, 133.5, 135.3, 138.4, 138.6, 
139.1, 140.2, 142.1, 143.7, 143.8, 144.0, 145.8, 150.5, 150.6, 153.5, 155.1, 156.5, 
179.8, 183.4, 185.9 (seven signals are missing, possibly because of signal 
overlapping); HRMS (ESI): m/z {[4-short·Na2][2ClO4]}2+ C144H164Cl2N4Na2O242+ 
calcd. 1224.5454, found 1224.5412. 
 
Pyridinium salt 6-long·Br.  A solution of 5-long (0.30 g, 0.34 mmol) and 
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4,4´-bipyridyl (1.06 g, 6.8 mmol) in CH3CN (40 mL) was heated under reflux for 2 
days and then the solvent was evaporated under reduced pressure.  The residue was 
washed with toluene (150 mL) to remove excess bipyridyl and then dried under 
vacuum to afford the pyridinium salt 6-long·Br (273 mg, 77%), which was used 
directly in the next step without further purification. M.p. > 192 °C ; 1H NMR (400 
MHz, CD3CN) δ 1.18–1.40 (m, 42 H), 1.56–1.64 (m, 2 H), 1.86–1.94 (m, 2H), 3.12 (s, 
3 H), 3.49 (t, J = 8 Hz, 2 H), 4.51 (t, J = 8 Hz, 2 H), 4.80 (s, 4 H), 6.84 (d, J = 8 Hz, 2 
H), 6.87 (d, J = 8 Hz, 2 H), 7.15 (d, J = 8 Hz, 4 H), 7.37 (d, J = 8 Hz, 4 H), 7.74 (d, J 
= 8 Hz, 2 H), 8.09 (d, J = 8 Hz, 2 H), 8.18 (d, J = 8 Hz, 2 H), 8.26 (d, J = 8 Hz, 2 H), 
8.74 (d, J = 8 Hz, 2 H), 8.80 (d, J = 8 Hz, 2 H) ; 13C NMR (100 MHz, CD3CN) δ 27.1, 
27.9, 28.4, 30.1, 30.4, 30.5, 30.6, 30.7, 30.8, 31.4, 32.1, 32.3, 35.6, 40.0, 52.8, 54.4, 
61.8, 114.4, 114.6, 120.3, 121.4, 123.1, 126.9, 127.2, 127.7, 132.9, 134.0, 135.2, 
141.4, 145.0, 150.5, 151.2, 154.0, 154.1, 155.2, 182.4, 185.8, 189.0 (three signals are 
missing, possibly because of signal overlapping); HRMS (ESI): m/z [6-long]+ 
C65H81N4O2+ calcd. 949.6359, found 949.6327. 
 
Rotaxane [4-long·Na2][4ClO4].  The bromide 7 (0.22 g, 0.39 mmol) was added to a 
solution of 6-long·Br (0.27 g, 0.26 mmol), the molecular cage 1 (0.23 g, 0.26 mmol), 
and NaClO4 (0.08 g, 0.65 mmol) in CH3CN (2 mL) and then the mixture was stirred 
at 50 °C for 7 days.  Saturated aqueous NaClO4 (3 mL) was added to the solution 
and the organic solvent was evaporated under reduced pressure.  The residue was 
extracted by CH2Cl2 (8 mL × 2) and the organic layer was collected and evaporated 
under reduced pressure.  The residue was then purified (SiO2; CH2Cl2/CH3CN, 4:1) 
to afford the rotaxane [4-long·Na2][4ClO4] as a deep-blue solid (0.24 g, 33%).  M.p. 
> 180 °C (dec.); 1H NMR (400 MHz, CD3CN) δ 1.20–1.44 (m, 80 H), 1.68–1.78 (br, 
2 H), 1.94–2.04 (br, 2 H), 3.25 (s, 3 H), 3.63–4.27 (m, 34 H), 4.59 (t, J = 8 Hz, 2 H), 
5.04 (s, 4 H), 5.14 (s, 4 H), 5.87 (s, 2 H), 6.14 (s, 4 H), 6.25 (s, 4 H), 6.75 (d, J = 8 Hz, 
2 H), 6.81 (d, J = 8 Hz, 2 H), 6.92 (d, J = 8 Hz, 4 H), 7.30–7.32 (m, 8 H), 7.39 (d, J = 
8 Hz, 2 H), 7.48 (d, J = 8 Hz, 4 H), 7.56 (s, 1 H), 7.59 (d, J = 8 Hz, 2 H), 7.67 (s, 2 H), 
7.75–7.78 (m, 4 H), 8.39–8.43 (m, 4 H), 8.89 (d, J = 8 Hz, 2 H), 9.02 (d, J = 8 Hz, 2 
H) ; 13C NMR (100 MHz, CD3CN) δ 18.6, 18.8, 26.7, 27.7, 28.2, 29.7, 30.2, 30.3, 
30.4, 30.5, 30.6, 31. 7, 31.8, 32.0, 34.8, 35.3, 36.5, 39.6, 41.6, 53.1, 56.7, 63.2, 65.5, 
67.1, 67.4, 69.5, 70.4, 104.0, 113.1, 114.2, 115.3, 115.5, 126.8, 126.9, 127.7, 128.4, 
128.6, 129.1, 131.1, 133.0, 133.1, 134.4, 136.2, 139.4, 139.5, 140.1, 141.1, 143.1, 
144.7, 144.8, 145.0, 146.6, 146.7, 150.9, 151.5, 151.6, 154.5, 156.2, 157.5, 180.8, 
184.5, 187.0 (11 signals are missing, possibly because of signal overlapping); HRMS 
(ESI): m/z {[4-long·Na2][ClO4]}3+ C152H180ClN4Na2O20 calcd. 820.7557, found 
820.7522. 
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